CPHI & PMEC China 2025 Leaderboard
  • More
    • Monday, May 12, 2025
    • About
    • Advertise
    • Subscribe
    • Contact

Pharma Journalist Pharma Journalist -

mRNA-Based Therapeutics Summit Leaderboard
  • More
    • Home
    • News
    • Drug Research
    • Clinical Trials
    • Manufacturing
    • Information Technology
    • Packaging & Labeling
    • Diseases
    • Resources
      • Articles
      • Projects
      • Case Studies
      • Industry Reports
      • Interviews
      • White Papers
    • Events
    • Press Releases
Pharma Journalist
  • Home
  • Sreoshi Chatterjee

Author

Sreoshi Chatterjee 452 posts 0 comments

Illumina appoints Dr. Phil Febbo as Chief Medical Officer

Mar 13, 2018
Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be…
Read More...

ASTRO imparts clinical guidelines for usage of whole breast radiation therapy for breast cancer

Mar 13, 2018
The American Society for Radiation Oncology declared a new clinical guideline for the usage of whole breast radiation therapy for breast Cancer augmenting the population of patients…
Read More...

Connexient rolls out Medinav 3.0 Navigator Edition

Mar 13, 2018
Connexient which is the healthcare leader in enterprise digital wayfinding , mapping and indoor navigation services set to roll out enhanced software version, MediNav Navigator 3.0.…
Read More...

Merrimack accentuates SHERLOC Study of MM-121 in Non-small Cell Lung Cancer

Mar 13, 2018
Merriimack Pharmaceuticals which is a clinical-stage oncology company focused on biomarker-defined cancers asserted that it is augmenting enrollment in the ongoing randomized Phase 2…
Read More...

BioVentrix announces first patient treated in ALIVE pivotal Clinical Trial

Mar 13, 2018
BioVentrix announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial. The trial is designed to demonstrate the…
Read More...

Check-Cap introduces EU Post Approval Study using Advanced C-Scan

Mar 13, 2018
Check-Cap which is a clinical-stage medical diagnostics company engaged in the development of C-Scan which is an ingestible capsule for preparation-free, colorectal cancer screening,…
Read More...

Cadent Therapeutics initiates Phase 1 Clinical study for CAD-1883

Mar 13, 2018
Cadent Therapeutics which is a precision neuroscience company developing novel medicines to restore movement and cognitive function in patients with neurological and psychiatric disease…
Read More...

Cantex Pharmaceutical’s CX-01 product in severe myeloid Leukemia studies reveal immense…

Mar 13, 2018
Cantex Pharmaceuticals which is a clinical stage  bio-pharmaceutical company developing proprietary pharmaceuticals that enhance the treatment of cancers and other fatal disorders…
Read More...

Pulsante Therapy clinched Prestigious Forfait Innovation Package to advance Medical Innovation for…

Mar 13, 2018
Autonomic Technologies asserted that the College of the French National Authority for Health issued a optimistic opinion on Forfait Innovation package for the Pulsante SPG…
Read More...

MYR Pharma GmbH completes MYR 202 Clinical Trial for Myrcludex B in HDV patients

Mar 13, 2018
MYR Pharma GmbH asserted the completion of MYR 202 Clinical Trial which is a Phase 2b study investigating Myrcludex B in chronic hepatitis Delta patients which is a more acute form of…
Read More...
Prev Next
9th IPF Summit
Tumor Models Summit Boston
ADC Linker & Conjugation Summit
6th Gene Therapy Analytical Development Summit Europe
Vendor Management & Outsourcing for Clinical Trials Summit
Induced Proximity-Based Drug Discovery Summit
Microbiome Movement Summit
CPHI & PMEC China 2025
World ADC Asia Summit
Innovation in Psychosis Therapeutics Summit
Structure-Based Drug Design Summit
GPCRs-Targeted Drug Discovery Summit
ALS Drug Development Summit
3rd Gene Therapy Potency Assay Summit
Obesity & Weight Loss Summit
Allogeneic Cell Therapies Summit
Cell & Gene Therapy Pricing & Reimbursement Summit
5th Inner Ear Disorders Therapeutics Summit
8th International Neoantigen Summit
3rd ADC Toxicity Summit
Liquid Biopsy for Precision Oncology East Coast
ESG in Life Sciences Summit West
TPD & Induced Proximity Pharma Partnering Summit
LEAP HR: Life Sciences East
Targeted Radiopharmaceuticals Summit US
GLP-1-Based Therapeutics Summit
Retinal Imaging Biomarkers & Endpoints Summit
Medical Device Software Development Summit
mRNA-Based Therapeutics Summit
Circular & Self-Amplifying RNA Therapeutics Summit
Precision in IBD
IMPACCT Real World Evidence Summit Europe
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Amneal and ApiJect Partner to Boost U.S. Sterile BFS Manufacturing Capacity
  • HAYA Therapeutics Secures $65M Series A to Advance RNA-Guided Therapies for Chronic Diseases
  • Genezen and Optieum Partner to Advance cGMP Manufacturing for Glioblastoma CAR-T Therapy
  • Adcentrx’s ADRX-0706 Nectin-4 ADC Earns FDA Fast Track for Advanced Cervical Cancer
  • Opus Genetics’ OPGx-LCA5 Gene Therapy Earns FDA RMAT Designation

Industry Reports

Pfizer Shares Update on Oral GLP-1 Candidate Danuglipron

AIRNA Secures $155M in Oversubscribed Series B for Alpha-1…

AbbVie Completes Acquisition of ImmunoGen

Sanofi to acquire Inhibrx, Inc., adding potential…

Esperion and Daiichi Sankyo Europe Announce $125 Million…

Press Releases

Speaker Interview with Anna Karmann, Chief Medical Officer,…

The Tumour Models Summit Hits Sweden!

5th Genome Editing Therapeutics Summit is only 3 weeks…

Celebrating More than a Decade of Excellence at the World…

Final Week to Save $350: Accelerate Your Gene Editing…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2025 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
  • About
  • Advertise
  • Subscribe
  • Contact

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLearn More